[Skip to Navigation]
September 1980

Mydriatic Solution for Outpatient Indirect Ophthalmoscopy

Author Affiliations

From the Massachusetts Eye and Ear Infirmary, Boston. Dr Sinclair is now with the Scheie Eye Institute, University of Pennsylvania School of Medicine, Philadelphia.

Arch Ophthalmol. 1980;98(9):1572-1574. doi:10.1001/archopht.1980.01020040424004

• A mydriatic used for outpatient indirect ophthalmoscopy should produce prompt, maximal, transient mydriasis after a single instillation. Cycloplegia or systemic side effects should be minimal. A solution of tropicamide with phenylephrine hydrochloride seems to achieve this most effectively. In a general retina clinic population, the percentage of pupils dilated, the degree of dilation, and the resistance of the dilation to intense illumination were used to evaluate various concentrations of the drugs. Eight-tenths percent tropicamide with 5% phenylephrine adequately dilated 98.8% of the eyes, among which 25% had dark irides and 9% were receiving miotic therapy. Reduction of the concentration of either component produced less adequate mydriasis; an increase of the tropicamide concentration resulted in a saturated solution with drug precipitate forming on storage and a less adequate dilation. With the optimal combination, 1 drop adequately dilates the general population; 2 drops appear no more effective than 1.

Add or change institution